These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 747144)

  • 21. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
    Werdermann K
    Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bronchodilator effects of terbutaline: route of administration and patterns of response.
    Dulfano MJ; Glass P
    Ann Allergy; 1976 Nov; 37(5):357-66. PubMed ID: 793454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of terbutaline in patients with myocardial infarct and concomitant chronic obstructive diseases of the lungs].
    Aksel'rud MM; Ustinov AG; Tatarskiĭ AR; Godiaev MIa; Zasimov AA
    Sov Med; 1988; (3):61-4. PubMed ID: 3413553
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

  • 26. Ventilation effects of fenoterol powder and freon-propelled aerosol in patients with asthma.
    Salorinne Y; Siren R
    Eur J Respir Dis Suppl; 1983; 130():6-8. PubMed ID: 6581064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the bronchodilating action and of the tolerance of fenoterol and isoproterenol aerosols.
    Takishima T; Sasaki T; Sasaki H; Sugiyama M; Nakamura M
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():540-2. PubMed ID: 6352316
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 29. Double-blind pretreatment of exercise-induced asthma with sequential inhalations of fenoterol from an aerosol and as a powder (second of two parts).
    Bundgaard A; Schmidt A
    Eur J Respir Dis Suppl; 1983; 130():66-72. PubMed ID: 6360704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of fenoterol powder capsules and fenoterol metered dose spray in bronchial asthma.
    Boye NP; Kornstad S
    Eur J Respir Dis Suppl; 1983; 130():9-11. PubMed ID: 6581065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient errors and preference with regard to the use of a bronchodilating spray and fenoterol (Berotec) powder.
    Kornstad S; Boye NP
    Eur J Respir Dis Suppl; 1983; 130():12-6. PubMed ID: 6581056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of Ditek in the treatment of patients with chronic obstructive bronchitis].
    Moskalev MN
    Klin Med (Mosk); 1996; 74(5):52-3. PubMed ID: 8999188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bronchodilator effect of fenoterol (Berotec).
    Powles AC
    N Z Med J; 1975 Mar; 81(535):249-51. PubMed ID: 1055321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticoids and selective beta 2-agonists: spirometric synergism and oxymetric antagonism].
    Díez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascón F; de Portugal Alvarez J
    Rev Clin Esp; 1982 Oct; 167(2):113-6. PubMed ID: 7178594
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fenoterol (Berotec)].
    Pedersen JT
    Ugeskr Laeger; 1976 Nov; 138(45):2817-8. PubMed ID: 790715
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of berotec and atropine on the ventilatory function and blood gases in patients with chronic bronchitis].
    Kurgan J
    Pol Tyg Lek; 1983 Jan; 38(5):149-51. PubMed ID: 6408625
    [No Abstract]   [Full Text] [Related]  

  • 37. [Obstructive respiratory diseases. Comparisons of dose effectiveness of Fenoterol (Berotec) given in diverse oral administration forms].
    Hertwig B
    ZFA (Stuttgart); 1979 Jan; 55(2):113-22. PubMed ID: 425634
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta2-selectivity of fenoterol. Comparison of intravenous and aerosol administration.
    Dürr MH; Baillie P
    S Afr Med J; 1975 Aug; 49(37):1517-8. PubMed ID: 1162529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cumulative dose response study for the comparison of the effect of inhalation of two dose sequences of fenoterol inhalation powder.
    Dirksen H; Groth S; Munch E
    Eur J Respir Dis Suppl; 1983; 130():54-8. PubMed ID: 6581063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of aerosol technique: does speed of inhalation matter?
    Williams TJ
    Br J Dis Chest; 1982 Jul; 76(3):223-8. PubMed ID: 7126434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.